These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 24532457)
1. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Zeng Z; Huang H; Huang L; Sun M; Yan Q; Song Y; Wei F; Bo H; Gong Z; Zeng Y; Li Q; Zhang W; Li X; Xiang B; Li X; Li Y; Xiong W; Li G Sci China Life Sci; 2014 Mar; 57(3):315-326. PubMed ID: 24532457 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1. Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345 [TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues. Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189 [TBL] [Abstract][Full Text] [Related]
4. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC. Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204 [TBL] [Abstract][Full Text] [Related]
5. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma. Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression. Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170 [TBL] [Abstract][Full Text] [Related]
7. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748 [TBL] [Abstract][Full Text] [Related]
8. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor. Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514 [TBL] [Abstract][Full Text] [Related]
9. Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Wong AM; Kong KL; Tsang JW; Kwong DL; Guan XY Cancer; 2012 Feb; 118(3):698-710. PubMed ID: 21720996 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-183 suppresses cancer stem-like cell properties in EBV-associated nasopharyngeal carcinoma. Cheung CC; Lun SW; Chung GT; Chow C; Lo C; Choy KW; Lo KW BMC Cancer; 2016 Jul; 16():495. PubMed ID: 27431799 [TBL] [Abstract][Full Text] [Related]
11. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections. Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781 [TBL] [Abstract][Full Text] [Related]
12. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. Chen SJ; Chen GH; Chen YH; Liu CY; Chang KP; Chang YS; Chen HC PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862214 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma. Cai L; Ye Y; Jiang Q; Chen Y; Lyu X; Li J; Wang S; Liu T; Cai H; Yao K; Li JL; Li X Nat Commun; 2015 Jul; 6():7353. PubMed ID: 26135619 [TBL] [Abstract][Full Text] [Related]
14. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment. Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622 [TBL] [Abstract][Full Text] [Related]
15. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Lo AK; To KF; Lo KW; Lung RW; Hui JW; Liao G; Hayward SD Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16164-9. PubMed ID: 17911266 [TBL] [Abstract][Full Text] [Related]
17. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707 [TBL] [Abstract][Full Text] [Related]
18. FosPeg® PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells. Wu RW; Chu ES; Huang Z; Xu CS; Ip CW; Yow CM J Photochem Photobiol B; 2013 Oct; 127():114-22. PubMed ID: 24013466 [TBL] [Abstract][Full Text] [Related]
19. Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases. Iizasa H; Kim H; Kartika AV; Kanehiro Y; Yoshiyama H Front Immunol; 2020; 11():367. PubMed ID: 32194570 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma. Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]